Resultados de la búsqueda 331-340 of 5126 for pneumococcal vaccination.
Mayo Clinic expert answers questions about the new COVID-19 vaccine Sept. 13, 2023, 04:15 p.m. CDT · The science behind weird body reactions Sept. 01, 2023 ...
This phase II trial studies the effect of pembrolizumab, dabrafenib, and trametinib before surgery in treating patients with BRAF V600E-mutated anaplastic ...
Its primary objective is to conduct a prospective observational study on the efficacy of using MP-TSCPC to treat glaucoma patients. Artisan Aphakia Lens for the ...
... vaccine? Nov. 21, 2023, 01:30 p.m. CDT · Mayo Clinic researchers demonstrate nearly 20% boost in adolescent HPV vaccination rates using comprehensive strategy ...
Spontaneous coronary artery dissection (SCAD) is uncommon but important cause of acute coronary syndrome and sudden cardiac death. There is very little data ...
Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements are ...
The rationale for using MUC1-stimulated T-cells to treat multiple myeloma is twofold. The first is that T-cell therapies have been shown to be active in myeloma ...
Rochester, Minn. This phase III trial compares the effect of vinorelbine with vincristine, dactinomycin, and cyclophosphamide (VAC) followed by vinorelbine and ...
agosto 2024. Mayo Clinic expert discusses updated COVID-19 vaccines Aug. 28, 2024, 03:00 p.m. CDT · Mayo Clinic Press launches new consumer health and wellness ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?